Select a Region North America

Expertise

Ellen Cappellino

SVP, Market Access & Patient Services

Expertise:

Brand Plan Development, Commercialization, HEOR, Market Access, Oncology, Patient Services, Pricing, Reimbursement & Market Access, Rare Disease, Specialty & Direct-to-Patient Distribution

As a proven expert in market access, Ellen Cappellino is helping EVERSANA quickly and safely deliver new treatments into the hands of the physicians and patients who will benefit from them. Ellen’s broad commercial background and extensive experience leading market access strategy and teams spans across large global and emerging biopharmaceutical companies. Now she’s leveraging her expertise to guide EVERSANA’s clients as they navigate the complex healthcare landscape with our top goal in mind – improving and transforming the patient journey.

Ellen holds an MBA from New York University and a BS from Albany College of Pharmacy and Health Sciences.

Articles by Ellen Cappellino

New Legislation Supports Payment for Digital Therapeutics

Earlier this month, the Access to Digital Prescription Therapeutics Act of 2022 was introduced by Rep. Mike Thompson (D-CA) to the U.S. House of Representatives as H.R. 7051 and by Sen. Shelley Moore Capito (R-WV) to the U.S. Senate as S. 3791. This precedent-setting legislation demonstrates the bicameral, bipartisan commitment to promoting the use of […]

Prescription Digital Therapeutics Coding: A Good First Step by CMS

The Centers for Medicare and Medicaid Services (CMS) recently issued a new code under the Healthcare Common Procedural Coding System (HCPCS) regarding prescription digital therapeutics (PDTs). These types of therapies are generally app- or device-based and can be used in any therapeutic category. This is certainly an exciting development for the PDT sector, as many […]

Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem

As physicians, patients and caregivers tirelessly fight complex diseases, a growing number of drug manufacturers are preparing to launch new oncology therapies. These high-science therapies are entering the market at rapid rates: Presently, there are 500 active cell and gene therapy agents in clinical development, with a great momentum building for immuno-oncology treatments. The Oncology […]

Telling the Whole Story: An Integrated Approach to Value Proposition Creation

Market shifts are underway, emphasizing the need for value propositions that are more seamless and integrated across functions. Adapting to these changes will be critical if manufacturers want to maximize pricing opportunities and avoid missing opportunities to generate data to demonstrate their product’s value effectively with different audiences. The most robust value propositions require expertise […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.